CVS Health Corporation $CVS Stock Holdings Reduced by Park National Corp OH

Park National Corp OH lowered its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.4% in the third quarter, Holdings Channel reports. The institutional investor owned 132,587 shares of the pharmacy operator’s stock after selling 6,031 shares during the period. Park National Corp OH’s holdings in CVS Health were worth $11,361,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the stock. Kilter Group LLC purchased a new position in CVS Health in the second quarter valued at about $27,000. Beaird Harris Wealth Management LLC boosted its holdings in shares of CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 195 shares in the last quarter. J.Safra Asset Management Corp purchased a new position in shares of CVS Health in the 2nd quarter worth approximately $30,000. Timbuktu Capital Management LLC bought a new position in shares of CVS Health during the 2nd quarter worth approximately $31,000. Finally, Dunhill Financial LLC purchased a new stake in CVS Health during the second quarter valued at approximately $32,000. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

CVS stock traded up $0.79 during trading on Monday, hitting $87.25. The stock had a trading volume of 3,572,879 shares, compared to its average volume of 8,245,941. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company’s 50-day moving average price is $94.68 and its two-hundred day moving average price is $92.01. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The stock has a market capitalization of $111.60 billion, a P/E ratio of 23.03, a PEG ratio of 0.84 and a beta of 0.60.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be paid a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s payout ratio is 70.37%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CVS. UBS Group restated a “buy” rating on shares of CVS Health in a research note on Tuesday, September 22nd. Wall Street Zen lowered CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Wells Fargo & Company boosted their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Finally, Mizuho increased their price target on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Twenty-two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $107.24.

About CVS Health

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.